- Home
- SLQT vs CTMX Comparison
SLQT vs CTMX Comparison
Compare SLQT & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- CTMX
- Stock Information
- Founded
- SLQT 1999
- CTMX 2008
- Country
- SLQT United States
- CTMX United States
- Employees
- SLQT N/A
- CTMX N/A
- Industry
- SLQT Specialty Insurers
- CTMX Biotechnology: Pharmaceutical Preparations
- Sector
- SLQT Finance
- CTMX Health Care
- Exchange
- SLQT Nasdaq
- CTMX Nasdaq
- Market Cap
- SLQT 343.7M
- CTMX 349.6M
- IPO Year
- SLQT 2020
- CTMX 2015
- Fundamental
- Price
- SLQT $2.07
- CTMX $2.28
- Analyst Decision
- SLQT Hold
- CTMX Strong Buy
- Analyst Count
- SLQT 2
- CTMX 3
- Target Price
- SLQT $4.38
- CTMX $5.67
- AVG Volume (30 Days)
- SLQT 2.8M
- CTMX 4.1M
- Earning Date
- SLQT 11-03-2025
- CTMX 11-06-2025
- Dividend Yield
- SLQT N/A
- CTMX N/A
- EPS Growth
- SLQT N/A
- CTMX 263.20
- EPS
- SLQT 0.01
- CTMX 0.49
- Revenue
- SLQT $1,526,594,000.00
- CTMX $141,100,000.00
- Revenue This Year
- SLQT $13.85
- CTMX N/A
- Revenue Next Year
- SLQT $13.64
- CTMX N/A
- P/E Ratio
- SLQT $155.28
- CTMX $4.66
- Revenue Growth
- SLQT 15.50
- CTMX 18.01
- 52 Week Low
- SLQT $1.62
- CTMX $0.40
- 52 Week High
- SLQT $6.86
- CTMX $3.10
- Technical
- Relative Strength Index (RSI)
- SLQT 45.92
- CTMX 57.29
- Support Level
- SLQT $2.01
- CTMX $2.02
- Resistance Level
- SLQT $2.77
- CTMX $2.17
- Average True Range (ATR)
- SLQT 0.19
- CTMX 0.15
- MACD
- SLQT -0.02
- CTMX 0.03
- Stochastic Oscillator
- SLQT 28.06
- CTMX 97.53
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.